eli lilly glp 1 LLY Stock Surges on Breakthrough Oral GLP-1 Trial Results FDA approves Eli Lilly's GLP-1

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone produced in the gut in response to eating

In late 2025, a seemingly narrow advertising dispute told a much bigger story about the GLP-1 market

(Bifidobacterium lactis BS01, Bifidobacterium breve BR03, Lactobacillus acidophilus LA02, Lactobacillus plantarum LP09, Lactobacillus rhamnosus LR06, Lactobacillus casei LC03, Bifidobacterium bifidum BB01, Streptococcus thermophilus YO8, Lactobacillus plantarum LP01, Lactobacillus rhamnosus LR05, Lactobacillus rhamnosus GG, Bifidobacterium longum BL03, Lactobacillus reuteri LRE02, Lactobacillus salivarius subsp. salivarius CRL1328, Bifidobacterium lactis BA05)

Moreover, the studies demonstrate a reduction in body weight (-6.2 to -12.9 kg), and other cardiovascular benefits by altering the lipid profile, reducing blood pressure, and visceral adiposity

Discover the optimal dose & how to safely adjust it for the best results